White blood cell subtypes, insulin resistance and β-cell dysfunction in high-risk individuals - The PROMISE cohort

Clinical Endocrinology

Volumn 81, Issue 4, 2014, Pages 536-541

  Lee, Chee Tin Christine ^a   Harris, Stewart B ^b   Retnakaran, Ravi ^c,d   Gerstein, Hertzel C ^e   Perkins, Bruce A ^c   Zinman, Bernard ^c,d   Hanley, Anthony J ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GRANULOCYTE; HIGH RISK PATIENT; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEUKOCYTE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MONOCYTE; NEUTROPHIL LYMPHOCYTE RATIO; OBESITY; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREAS ISLET BETA CELL DYSFUNCTION; PROSPECTIVE STUDY; RISK FACTOR; CYTOLOGY; IMMUNOLOGY; MIDDLE AGED; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PHYSIOLOGY;

ADULT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GRANULOCYTES; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LEUKOCYTES; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PROSPECTIVE STUDIES;

EID: 84908103010     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12390     Document Type: Article

References (22)

1. Donath, M.Y. & Shoelson, S.E. (2011) Type 2 diabetes as an inflammatory disease. Nature Reviews Immunology, 11, 98-107.
2. Stock, W. & Hoffman, R. (2000) White blood cells 1: non-malignant disorders. Lancet, 355, 1351-1357.
3. Gkrania-Klotsas, E., Ye, Z., Cooper, A.J. et al. (2010) Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies. PLoS ONE, 5, e13405.
4. Imtiaz, F., Shafique, K., Mirza, S.S. et al. (2012) Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. International Archives of Medicine, 5, 2.
5. Bhat, T., Teli, S., Rijal, J. et al. (2013) Neutrophil to lymphocyte ratio and cardiovascular disease: a review. Expert Review of Cardiovascular Therapy, 11, 55-59.
6. Stern, M.P. (1995) Diabetes and cardiovascular disease. The "Common soil" hypothesis. Diabetes, 44, 369-374.
7. Ingelsson, E., Hulthe, J. & Lind, L. (2008) Inflammatory markers in relation to insulin resistance and the metabolic syndrome. European Journal of Clinical Investigation, 38, 502-509.
8. Marques-Vidal, P., Mazoyer, E., Bongard, V. et al. (2002) Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care, 25, 1371-1377.
9. Vozarova, B., Weyer, C., Lindsay, R.S. et al. (2002) High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes, 51, 455-461.
10. Temelkova-Kurktschiev, T., Siegert, G., Bergmann, S. et al. (2002) Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism, 51, 743-749.
11. Hanley, A.J., Retnakaran, R., Qi, Y. et al. (2009) Association of hematological parameters with insulin resistance and b-cell dysfunction in non-diabetic subjects. Journal of Clinical Endocrinology and Metabolism, 94, 3824-3832.
12. World Health Organization. (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Organization, Geneva.
13. Matsuda, M. & DeFronzo, R.A. (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care, 22, 1462-1470.
14. Matthews, D.R., Hosker, J.P., Rudenski, A.S. et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia, 28, 412-419.
15. Wareham, N.J., Phillips, D.I., Byrne, C.D. et al. (1995) The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabetic Medicine, 12, 931.
16. Retnakaran, R., Shen, S., Hanley, A.J. et al. (2008) Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity (Silver Spring), 16, 1901-1908.
17. Xu, H., Barnes, G.T., Yang, Q. et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesityrelated insulin resistance. Journal of Clinical Investigation, 112, 1821-1830.
18. Rajwani, A., Cubbon, R.M. & Wheatcroft, S.B. (2012) Cell-specific insulin resistance: implications for atherosclerosis. Diabetes/metabolism Research and Reviews, 28, 627-634.
19. Chmelar, J., Chung, K.J. & Chavakis, T. (2013) The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance. Thrombosis and Haemostasis, 109, 399-406.
20. Bhargava, P. & Lee, C.H. (2012) Role and function of macrophages in the metabolic syndrome. The Biochemical Journal, 442, 253-262.
21. Donath, M.Y., Boni-Schnetzler, M., Ellingsgaard, H. et al. (2009) Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes. Physiology (Bethesda), 24, 325-331.
22. Chatzigeogiou, A., Karalis, K.P., Bornstein, S.R. et al. (2012) Lymphocytes in obesity-related adipose tissue. Diabetologia, 55, 2583-2592.